产品说明书

1A-116

Print
Chemical Structure| 1430208-73-3 同义名 : -
CAS号 : 1430208-73-3
货号 : A724348
分子式 : C16H16F3N3
纯度 : 99%+
分子量 : 307.31
MDL号 : MFCD31619254
存储条件:

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(341.67 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 As a small GTPase, Rac1 switches between active and inactive states at various subcellular locations that include the plasma membrane, nucleus and mitochondria. Once activated, Rac1 interacts with a range of effectors that then mediate various biological functions[1]. 1A-116 is a specific Rac1 inhibitor[2]. 1A-116 shows lesser effect on MCF7::pcDNA.3 cells than on MCF7::C1199 cells. 1A-116 treatment decreases phospho-PAK1 levels in a time-dependent manner. The presence of 1A-116 reverts the PAK1 phosphorylation induced by 4-hydroxytamoxifen (Tam). The presence of 1A-116 also effectively reverts Rac1-PAK1-mediated estrogen receptor (ER) phosphorylation at Ser305[2]. 1A-116 shows a significant increase in antiproliferative activity on F3II cells, showing an IC50 value of 4 µM. A-116 also dramatically impaired Rac1 activation at low micromolar range (1 µM)[3]. Daily treatment of mice with compound 1A-116 at 3mg/kg reduced about 60% the formation of total metastatic lung colonies. A significant antitumor activity is obtained for macronodules (more than 1 mm in diameter) by treatment with 1A-116 in this highly aggressive breast cancer model. The treatment with 1A-116 reduced the total lung weight compare to the control group, leading to a total weight similar to the average pulmonary weight of Balb/c mice[3].
作用机制 Several hydrogen bonds are established between the guanidine nitrogen atoms and residues Asp57 and Ser71. Moreover, pi-stacking interactions are observed between the methylated aromatic ring of the 1A-116 and the aromatic ring of Trp56.
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.27mL

3.25mL

1.63mL

32.54mL

6.51mL

3.25mL

参考文献

[1]Payapilly A, Malliri A. Compartmentalisation of RAC1 signalling. Curr Opin Cell Biol. 2018 Oct;54:50-56. doi: 10.1016/j.ceb.2018.04.009. Epub 2018 Apr 30. PMID: 29723737.

[2]Gonzalez N, Cardama GA, Comin MJ, Segatori VI, Pifano M, Alonso DF, Gomez DE, Menna PL. Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells. Cell Signal. 2017 Jan;30:154-161. doi: 10.1016/j.cellsig.2016.12.002. Epub 2016 Dec 7. PMID: 27939839.

[3]Cardama GA, Comin MJ, Hornos L, Gonzalez N, Defelipe L, Turjanski AG, Alonso DF, Gomez DE, Menna PL. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines. Anticancer Agents Med Chem. 2014;14(6):840-51. doi: 10.2174/18715206113136660334. PMID: 24066799; PMCID: PMC4104455.